AstraZeneca China selects Digital Control Room Cookie for Governance, Risk and Compliance

In 2023, AstraZeneca China, a China based Life Sciences organization with 11000 employees and revenues of $4.5B selected Digital Control Room Cookie for Governance, Risk and Compliance while displacing Legacy, and integrating with the existing systems being used.

Customer	Vendor	Old Product	New Product	Category	Market	Users	VAR/SI	When	Live
AstraZeneca China	Digital Control Room	Legacy	Digital Control Room Cookie	Governance, Risk and Compliance	TRM	n/a	n/a	2023	2023

Discover the latest software purchases and digital transformation initiatives being undertaken by AstraZeneca China and its business and technology executives by accessing the entire AstraZeneca China and its business and technology executives by becoming a Premium Subscriber. On a continuous basis, our research team identifies and updates the on-prem and cloud applications that are being used by AstraZeneca China employees from publicly available data (Press Releases, Customer References, Case Studies, Success Stories, Testimonials, RFP, RFI, etc.) as well as proprietary sources, and incorporate them into the customer profile.